Correspondence

References

• Thorne E G. long-term clinical experience with topical retinoid. Br J Dermatol 1992; 127(Suppl 41)31–6
   PubMedGoogle Scholar
• Katsambas A, Towarky A A, Stratigos J. Topical clindamycin phosphate compared to oral tetracycline in the treatment of acne vulgaris. Br J Dermatol 1987; 116: 387–91
   PubMed Web of Science ®Google Scholar
• Lookingbill D P, Marks J D, Jr. Acne. Principles of Dermatology., 2nd edn, D P Lookingbill, J D. Marks, Jr. W.B. Saunders Co, Philadelphia 1992; 189–94
   Google Scholar
• Marks R. Effects of tretinoin on the skin: an update. 1990, A scientific service provided by CILAG AG Products, CH-6300, Zug, Switzerland
   Google Scholar
• Kato T, Rokugo M, Terui T, et al. Successful treatment of psoriasis with topical application of active vitamin D3 analogue, la,24-dihydroxycholecalciferol. Br I Dermatol 1986; 115: 431–3
   PubMed Web of Science ®Google Scholar
• Kimura H. Investigation of usefulness of TV-02 ointment in the treatment of psoriasis: double-blind, right-left comparison with betamethasone 17-valerate ointment. Nishinihon I Dermatol 1989; 51: 963–9
   Google Scholar
• Kimura H. Investigation of clinical effects of TV-02 ointment in the treatment of psoriasis. Nishinihon] Dermatol 1989; 51: 970–9
   Google Scholar
• Speight E L, Farr P M. Calcipotriol improves the response of psoriasis to PUVA. Br] Dermatol 1994; 130: 79–82
   PubMed Web of Science ®Google Scholar
• Danno K. Psoralen photochemotherapy and its action mechanisms. Frontiers of photobiology, A Shima, M Ichihashi, Y Fujiwara, et al. Excerpta Medica, Amsterdam, London, New York and Tokyo 1993; 97–9
   Google Scholar
• Kato T, Terui T, Tagami H. Topically active vitamin D3 analogue, la,24-dihydroxycholecalciferol, has an antiproliferative effect on the epidermis of guinea-pig skin. Br J Dermatol 1987; 117: 528–30
   PubMed Web of Science ®Google Scholar
• van de Kerkhof P CM. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br] Dermatol 1995; 132: 675–82
   PubMed Web of Science ®Google Scholar
• Gerritsen M JP, Boezeman J BM, van Vlijmen-Willems I MJJ, et al. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br] Dermatol 1994; 131: 57–63
   PubMed Web of Science ®Google Scholar
• de Jong E MGJ, van de Kerkhof P CM. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC 903: modulations and interrelations. Br] Dermatol 1991; 124: 221–9
   PubMed Web of Science ®Google Scholar
• Nieboer C, Verburgh C A. Psoriasis treatment with vitamin D3 analogue MC 903. Br I Dermatol 1992; 126: 302–3
   PubMed Web of Science ®Google Scholar
• Tomita Y, Torinuki W, Tagami H. Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure. J Invest Dermatol 1988; 90: 882–4
   PubMed Web of Science ®Google Scholar
• van de Kerkhof P CM. Dithranol treatment for psoriasis: after 75 years, still going strong!. Eur J Dermatol 1991; 1: 79–88
   Google Scholar
• Ingram J T. The approach to psoriasis. BMJ 1953; 2: 591–4
   PubMed Web of Science ®Google Scholar
• Laum J H, Steigleder G K. Behandlungsdauer bei kombinierter Cignolin-Salicylsaure-Vaseline-Behandlung bei Psoriasis. Hautarzt 1972; 23: 204–6
   PubMedGoogle Scholar
• Wilson P D, Ive F A. Dithrocream in psoriasis. Br J Dermatol 1980; 102: 105–6
   Google Scholar
• Duschet P, Schwarz Th, Pusch M, et al. Anthralin minute entire skin treatment: a follow up and comparison with methoxsalen plus ultraviolet light. Arch Dermatol 1987; 123: 428–9
   PubMedGoogle Scholar
• Schaefer H, Farber E M, Goldberg L, et al. Limited application period for dithranol in psoriasis. Br j Dermatol 1980; 102: 571–3
   PubMed Web of Science ®Google Scholar
• Runne U, Kunze J. Short-duration ('minutes') therapy with dithranol for psoriasis: a new outpatient regimen. Br J Dermatol 1982; 106: 135–40
   PubMed Web of Science ®Google Scholar
• de Mare S, Calis N, Hartog den H, et al. Out patient treatment with short contact dithranol. The impact of frequent concentration adjustments. Acta Derm Venereol 1989; 69: 449–51
   PubMed Web of Science ®Google Scholar
• Seville R H. Simplified dithranol treatment for psoriasis. Br J Dermatol 1975; 93: 205–8
   PubMed Web of Science ®Google Scholar
• Kostler E, Seebacher C. KonventionelleTherapie Methoden der Psoriasis Vulgaris. Dermatol Monatschr 1980; 166: 45–6
   PubMedGoogle Scholar
• Schulze H J, Steigler G K. Erfahrungen bei Halbseitenbe-handlung mit Teerzusatz zur Cignolin Salicylsaure - weisse Vaselin Therapie der Psoriasis Vulgaris. Z. Hautkr 1984; 59: 1984
   Google Scholar
• Ros J JW, Meer van der Y G. Preparation, analysis and stability of oil-in-water creams containing dithranol. Eur J HospPharm 1991; 1: 77–84
   Google Scholar
• Frederiksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238–44
   PubMedGoogle Scholar
• Walker G B, Harrison P V, Seville R H., et al. Short contact dithranol therapy: advantages of a stiff emulsifying ointment base. Br J Dermatol 1989; 120: 277–83
   PubMed Web of Science ®Google Scholar
• Hindryckx P. Bersaques] de, Short duration dithranol therapy for psoriasis. Dermatologica 1983; 167: 304–6
   PubMedGoogle Scholar
• de Jong E MGJ, van de Kerkhof P CM. Short contact dithranol treatment of psoriasis, using a novel emulsifying ointment (Hermal-AWR): changes in clinical scores and in parameters for inflammation, proliferation and keratinization. Eur J Dermatol 1992; 2: 552–8
   Google Scholar
• de Mare S, Calis N, Hartog den H, et al. The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol 1988; 1: 259–64
   PubMedGoogle Scholar
• Schwarz Th, Gschaint F. Anthralin minute entire skin treatment. Arch Dermatol 1985; 121: 1512–15
   PubMedGoogle Scholar
• Christensen O B, Hoist R, Hradil E. Clinical response and side effects in the treatment of psoriasis with UVB and a novel dithranol formulation. Acta Derm Venereol 1989; 146: 96–101
   Google Scholar